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RatsAbstract Physiologically, it is known that thioacetamide (TAA) toxicity is generally associated
with hepatic ﬁbrosis induction, complicated metabolic disorders and health problems. The capabil-
ity of extracts of olive and rosemary leaves to attenuate the severe physiological disturbances
induced by thioacetamide (TAA) intoxication in male rats has been evaluated. Healthy male Wistar
rats were used in the present study and were divided randomly into eight groups. Rats of the ﬁrst
group were served as normal control. Rats of the second group were administrated with TAA. Rats
of the third, fourth and ﬁfth groups were exposed to TAA plus olive leaves extract, TAA plus rose-
mary leaves extract and TAA plus olive and rosemary leaves extracts respectively. The sixth, sev-
enth and eighth groups were supplemented with olive leaves extract, rosemary leaves extract, and
olive and rosemary leaves extracts respectively. After 12 weeks of experimental treatments, the lev-
els of serum glucose, total protein, albumin and high density lipoprotein cholesterol were signiﬁ-
cantly decreased, while the levels of triglycerides, cholesterol, low density lipoprotein cholesterol,
very low density lipoprotein cholesterol, creatine kinase and lactate dehydrogenase were statistically
increased in rats exposed to TAA. Administration of the studied extracts inhibited the hematobio-
chemical parameters and improved the physiological disturbances induced by TAA intoxication.
Additionally, most improvements were noted in rats administrated with rosemary leaves extract fol-
lowed by olive and rosemary leaves extracts and olive leaves extract. These results suggested that the
effect of these extracts might be due to their antioxidant activities against TAA toxicity.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The World Health Organization (WHO) estimates that more
than 25% of the global burden of disease is linked to environ-
mental factors, including exposures to toxic chemicals. Tens of
thousands of chemicals are currently in use, and hundreds
more are introduced every year. Because current chemical
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of chemicals have been fully evaluated for potential human
health effects. Thioacetamide (TAA) was originally used to
control the decay of oranges and then as a fungicide (Childs
and Siegler, 1945). TAA is a potent hepatotoxicant which
requires metabolic activation by the mixed-function oxidases.
For its toxicity, thioacetamide requires oxidation to its S-oxide
and then further to reactive S,S-dioxide form which ultimately
attacks lipids and proteins (Hajovsky et al., 2012). Further-
more, the effects of TAA are not limited to the liver as pro-
found structural and functional changes have been described
in the thymus (Barker and Smuckler, 1974), the kidney
(Barker and Smuckler, 1974; Caballero et al., 2001), the intes-
tine (Ortega et al., 1997; Caballero et al., 2001), the spleen
(Al-Bader et al., 2000) and the lung (Latha et al., 2003).
The pharmacological treatment of disease began long ago
with the use of herbs (Schulz et al., 2001). Herbal medicine is
the use of plants, plant parts, their water or solvent extracts,
essential oils, gums, resins, exudates or other forms of
advanced products made from plant parts used therapeutically
to provide proactive support of various physiological systems;
or, in a more conventional medical sense, to treat, cure, or pre-
vent a disease in animals or humans (Weiss and Fintelmann,
2000). About 70–80% of the world populations, particularly
in the developing countries, rely on non-conventional medicine
in their primary healthcare as reported by the World Health
Organization (Akerele, 1993). The use of herbal medicines
and phytonutrients or nutraceuticals continues to expand rap-
idly across the world with many people now resorting to these
products for treatment of various health challenges in different
national healthcare settings (WHO, 2004). This interest in
drugs of plant origin is due to several reasons, namely, conven-
tional medicine can be inefﬁcient (e.g. side effects and ineffec-
tive therapy), abusive and/or incorrect use of synthetic drugs
results in side effects and other problems, a large percentage
of the world’s population does not have access to conventional
pharmacological treatment, and folk medicine and ecological
awareness suggests that natural products are harmless.
Olive tree (Olea europaea, Oleaceae) is a longevous plant,
anciently known in the Mediterranean basin (Melillo, 1994).
The olive tree has been widely accepted as one of the species
with the highest antioxidant activity via its oil, fruits, and
leaves. It is well known that the activity of the olive tree
byproduct extracts in medicine and food industry is due to
the presence of some important antioxidant and phenolic com-
ponents to prevent oxidative degradations. Olive leaves are
considered a cheap raw material and a useful source of high-
added value products (Briante et al., 2002; Jemai et al.,
2008). The main phenolic compound in olive leaves is the gly-
cosylated form of oleuropein (Amro et al., 2002; Visioli et al.,
2002). It is a natural phenolic antioxidant, which is present in
high concentration in olives, olive oil and olive tree leaves
(Andreadou et al., 2007). Rosemary plant with the scientiﬁc
name of Rosmarinus ofﬁcinalis belongs to the Lamiaceae fam-
ily. Four main categories of compounds found in rosemary
include ﬂavonoids, phenols, volatile oil, and terpenoids
(Barnes et al., 2007). Leaves of rosemary possess a variety of
bioactivities, including antioxidant, antitumor, antiinﬂamma-
tory, treat headaches and anti-HIV (Aruoma et al., 1996;
Altinier et al., 2007). The present study is aimed to investigate
the role of olive and rosemary leaves extracts against TAA tox-
icity in Wistar male rats.2. Materials and methods
2.1. Extraction of olive and rosemary leaves
The methods of Sakr and Lamfon (2012), and Al-Attar and
Abu Zeid (2013) were used for the preparation of olive and
rosemary leaves extracts with some modiﬁcations. Fine quali-
ties of olive and rosemary leaves were obtained from a com-
mercial market, Jeddah, Saudi Arabia. The leaves were
scientiﬁcally deﬁned by the herbarium of Biological Sciences
Department, Faculty of Sciences, King Abdulaziz University,
Jeddah, Saudi Arabia. The leaves were thoroughly washed
and dried at room temperature. The dried olive leaves (50 g)
were powdered and added to 2 L of hot water in a ﬂask. After
6 h, the mixture was slowly boiled for 1 h. After boiling period,
the mixture was cooled at room temperature and it was gently
subjected to an electric mixer for 10 min. Also, the dried rose-
mary leaves (50 g) were powdered and added to 2 L of hot
water in a ﬂask. After 6 h, the mixture was slowly boiled for
1 h. After boiling period, the mixture was cooled at room tem-
perature and it was gently subjected to an electric mixer for
10 min. Thereafter the solutions of olive and rosemary leaves
were ﬁltered. Finally, the ﬁltrates were evaporated in an oven
at 40 C to produce dried residues (active principles). With ref-
erences to the powdered samples, the yield means of the olive
and rosemary extracts were 18.7% and 20.6% respectively.
Furthermore, these extracts were prepared every 2 weeks and
stored in a refrigerator for experimentation.
2.2. Animal models
Forty-eight Wistar male rats weighing 72.6–103.4 g were
obtained from the Experimental Animal Unit of King Fahd
Medical Research Center, King Abdulaziz University, Jed-
dah, Saudi Arabia. Rats were acclimatized to the experimen-
tal laboratory having temperature 20 ± 1 C, controlled
humidity conditions (65%) and 12:12 h light:dark cycle.
Rats were housed in standard plastic cages, fed with stan-
dard diet, and water ad libitum. All experimental procedures
were conducted in accordance with ethical guidelines of the
Animal Care and Use Committee of King Abdulaziz
University.
2.3. Experimental design
The animals were divided into eight groups of six animals each
and then subjected to one of the following treatments:
Group 1: Rats were served as controls and intraperitoneally
injected with saline solution (0.9% NaCl), twice weekly for
12 weeks.
Group 2: Rats were given 300 mg/kg body weight of TAA
(Sigma–Aldrich Corp., St. Louis, MO, USA) by intraperi-
toneal injection, twice weekly for 12 weeks.
Group 3: Rats were intraperitoneally injected with TAA at
the same dose given to group 2 and were orally supple-
mented with olive leaves extract at a dose of 200 mg/kg
body weight/day for 12 weeks.
Group 4: Rats were intraperitoneally injected with TAA at
the same dose given to group 2 andwere orally supplemented
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weight/day for 12 weeks.
Group 5: Rats were intraperitoneally injected with TAA at
the same dose given to group 2 and were supplemented with
olive leaves extract (100 mg/kg body weight/day) and rose-
mary leaves extract (100 mg/kg body weight/day) for
12 weeks.
Group 6: Rats intraperitoneally received saline solution at
the same dose given to group 1 and were orally supple-
mented with olive leaves extract at the same dose given to
group 3 for 12 weeks.
Group 7: Rats were intraperitoneally received saline
solution at the same dose given to group 1 and were orally
supplemented with rosemary leaves extract at the same dose
given group 4 for 12 weeks.
Group 8: Rats were intraperitoneally received saline solu-
tion at the same dose given to group 1 and were supple-
mented with olive and rosemary leaves extracts at the
same dose given to group 5 for 12 weeks.
2.4. Blood sampling
After 12 weeks, the experimental animals were fasted for 12 h,
water was not restricted, and then anesthetized with diethyl
ether. Blood samples were collected from orbital venous plexus
in non-heparinized tubes, centrifuged at 2500 rpm for 15 min.
Blood sera were carefully separated and stored frozen. The
level of serum glucose was determined using the method of
Trinder (1969). The method of Peters (1968) was carried out
to measure the level of serum total protein. The level of serum
albumin was measured according to the method of Doumas
et al. (1971). To estimate the triglycerides value, Fossati and
Prinicip method (1982) was used. The method of Richmond
(1973) was used to determine the level of serum cholesterol.
The method of Warnick (1983) was used to determine the
value of serum high density lipoprotein cholesterol (HDL-C).
The level of serum low density lipoprotein cholesterol (LDL-
C) was estimated according to the equation of Friedewald
et al. (1972).
LDL C ¼ Total cholesterolHDL triglycerides=5
Serum very low density lipoprotein cholesterol (VLDL-C)
was evaluated using the following equation:
VLDL C ¼ Triglycerides=2:175
Serum creatine kinase (CK) level was determined according
to the method of Horder et al. (1991). The method of Weishaar
(1975) was used to measure the value of serum lactate dehydro-
genase (LDH).
2.5. Statistical analysis
The statistical differences of all data were determined by two-
way analysis of variance (ANOVA). All values were expressed
as mean ± standard deviation (SD) for six observations. Sta-
tistical probability of less than 0.05 was used as a criterion
for signiﬁcance. All data were evaluated for statistical signiﬁ-
cance using the Statistical Package for Social Sciences (SPSS)
for Windows, version 12.0.3. Results
The levels of serum glucose were statistically decreased in rats
exposed to TAA (34.8%), TAA plus olive leaves extract
(28.5%), TAA plus rosemary leaves extract (33.2%), TAA plus
olive and rosemary leaves extracts (27.3%), olive leaves extract
(18.5%), rosemary leaves extract (11.1%), and olive and rose-
mary leaves extracts (6.7%) when compared to control rats
(Table 1).
In comparison with control data, the levels of serum total
protein were signiﬁcantly diminished in rats administrated
with TAA (12.9%), TAA plus olive leaves extract (9.2%).
No statistically signiﬁcant difference was observed in this
parameter in rats treated with TAA plus rosemary leaves
extract, TAA plus olive and rosemary leaves extracts, olive
leaves extract, rosemary leaves extract, and olive and rosemary
leaves extracts. The level of serum albumin was signiﬁcantly
decreased from corresponding control values in rats treated
with TAA (11.9%). In comparison with the control group,
there were no signiﬁcant changes in the levels of serum albu-
min in TAA plus olive leaves extract, TAA plus rosemary
leaves extract, TAA plus olive and rosemary leaves extracts,
olive leaves extract, rosemary leaves extract, and olive and
rosemary leaves extracts treated rats. The levels of serum tri-
glycerides were statistically increased in rats exposed to TAA
(77.9%), TAA plus olive leaves extract (48.5%), TAA plus
rosemary leaves extract (47.1%), and TAA plus olive and rose-
mary leaves extracts (48.5%) as compared with control rats.
Remarkable elevations in the level of serum cholesterol were
observed in rats treated with TAA (105.3%), TAA plus olive
leaves extract (63.2%), TAA plus rosemary leaves extract
(51.2%), and TAA plus olive and rosemary leaves extracts
(67.9%) when compared to control rats. Insigniﬁcant changes
of serum triglycerides and cholesterol levels were noted in olive
leaves extract, rosemary leaves extract, and olive and rosemary
leaves extracts treated rats as compared with control rats
(Table 1).
As shown in Table 2, a signiﬁcant decline in the level of
serum HDL-C was noted in rats exposed to TAA (17.8%)
compared with control rats. In comparison with the control
group, there were no signiﬁcant alterations in the levels of
serum HDL-C in TAA plus rosemary leaves extract, TAA plus
olive and rosemary leaves extracts, olive leaves extract, rose-
mary leaves extract, and olive and rosemary leaves extracts
treated rats. The levels of serum LDL-C were statistically
enhanced in rats treated with TAA (211.3%), TAA plus olive
leaves extract (123.6%), TAA plus rosemary leaves extract
(97.2%), and TAA plus olive and rosemary leaves extracts
(130.2%) as compared with control rats. The levels of serum
VLDL-C were statistically increased in rats subjected to
TAA (80.7%), TAA plus olive leaves extract (54.8%), TAA
plus rosemary leaves extract (48.4%), and TAA plus olive
and rosemary leaves extracts (51.6%) as compared with con-
trol rats. Insigniﬁcant alterations of serum LDL-C and
VLDL-C levels were observed in rats supplemented with olive
leaves extract, rosemary leaves extract, and olive and rosemary
leaves extracts as compared with control rats. The level of
serum CK was signiﬁcantly increased from corresponding con-
trol values in rats treated with TAA (103.4%) and TAA plus
olive leaves extract (21.8%). In comparison with the control
group, there were no signiﬁcant changes in the levels of serum
Table 2 The levels of serum HDL-C, LDL-C, VLDL-C, CK and LDH of control, TAA, TAA plus olive leaves extract, TAA plus rosemary leaves extract, TAA plus olive and
rosemary leaves extracts, olive leaves extract, rosemary leaves extract, and olive and rosemary leaves extracts treated rats (n= 6). Percentage changes are included in parentheses.
Treatments Parameters
HDL-C LDL-C VLDL-C CK LDH
(mmol/L) (mmol/L) (mmol/L) (U/L) (U/L)
Control 0.90 ± 0.03 1.06 ± 0.07 0.31 ± 0.03 284.67 ± 18.24 523.67 ± 32.14
TAA 0.74 ± 0.04 (17.8) 3.30 ± 0.53 (+211.32) 0.56 ± 0.09 (+80.7) 579.12 ± 64.22 (+103.4) 1816.33 ± 282.29 (+246.9)
TAA+ olive leaves 0.82 ± 0.08 (8.9) 2.37 ± 0.52 (+123.6) 0.48 ± 0.06 (+54.8) 346.69 ± 40.58 (+21.8) 594.33 ± 104.09 (+13.5)
TAA+ rosemary leaves 0.88 ± 0.03 (2.22) 2.09 ± 0.35 (+97.2) 0.46 ± 0.05 (+48.4) 338.25 ± 61.56 (+18.8) 547.50 ± 70.83 (+4.6)
TAA+ olive and rosemary leaves 0.86 ± 0.06 (4.4) 2.44 ± 0.47 (+130.2) 0.47 ± 0.08 (+51.6) 328.33 ± 62.75 (+15.3) 589.67 ± 105.02 (+12.6)
Olive leaves 0.89 ± 0.04 (1.1) 0.99 ± 0.04 (6.6) 0.30 ± 0.03 (3.3) 289.50 ± 18.58 (+1.7) 527.17 ± 27.88 (+0.7)
Rosemary leaves 0.90 ± 0.04 (0.0) 0.95 ± 0.11 (10.4) 0.30 ± 0.02 (3.3) 282.40 ± 21.53 (0.8) 513.00 ± 16.35 (2.0)
Olive and rosemary leaves 0.89 ± 0.03 (1.1) 1.02 ± 0.09 (3.8) 0.31 ± 0.02 (0.0) 284.26 ± 31.38 (0.1) 494.67 ± 94.66 (5.5)
Table 1 The levels of serum glucose, total protein, albumin, triglycerides and cholesterol of control, TAA, TAA plus olive leaves extract, TAA plus rosemary leaves extract, TAA plus
olive and rosemary leaves extracts, olive leaves extract, rosemary leaves extract, and olive and rosemary leaves extracts treated rats (n= 6). Percentage changes are included in
parentheses.
Treatments Parameters
Glucose Total protein Albumin Triglycerides Cholesterol
(mmol/L) (g/L) (g/L) (mmol/L) (mmol/L)
Control 6.59 ± 0.35 69.33 ± 5.61 11.83 ± 0.75 0.68 ± 0.05
TAA 4.30 ± 0.14 (34.8) 60.42 ± 2.25 (12.9) 10.42 ± 1.28 (11.9) 1.21 ± 0.20 (+ 77.94) 4.29 ± 0.53 (+ 105.3)
TAA+ olive leaves 4.71 ± 0.27 (28.5) 63.00 ± 2.10 (9.2) 10.84 ± 1.33 (8.4) 1.01 ± 0.13 (+48.5) 3.41 ± 0.50 (+63.2)
TAA+ rosemary leaves 4.40 ± 0.25 (33.23) 69.92 ± 6.73 (+0.9) 13.08 ± 1.11 (+10.4) 1.00 ± 0.11(+47.1) 3.16 ± 0.32 (+51.2)
TAA+ olive and rosemary leaves 4.79 ± 0.31 (27.3) 68.75 ± 2.32 (0.8) 12.81 ± 1.60 (+8.3) 1.01 ± 0.17(+48.5) 3.51 ± 0.48 (+67.9)
Olive leaves 5.37 ± 0.39 (18.5) 65.67 ± 2.26 (5.3) 11.58 ± 0.49 (2.1) 0.65 ± 0.06 (4.4) 2.01 ± 0.05 (3.8)
Rosemary leaves 5.86 ± 0.44 (11.1) 66.42 ± 2.50 (4.2) 12.00 ± 0.63 (+1.4) 0.65 ± 0.05 (4.4) 1.98 ± 0.11 (5.3)
Olive and rosemary leaves 6.15 ± 0.41 (6.7) 64.17 ± 4.12 (7.4) 11.25 ± 0.88 (4.9) 0.66 ± 0.04 (2.9) 2.05 ± 0.10 (1.9)
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rosemary leaves extracts, olive leaves extract, rosemary leaves
extract, and olive and rosemary leaves extracts treated rats. In
comparison with control, the administration of TAA alone sig-
niﬁcantly increased (246.9%) the activity of serum LDH. The
activity of this enzyme in rats treated with TAA plus olive
leaves extract, TAA plus rosemary leaves extract, TAA plus
olive and rosemary leaves extracts, olive leaves extract, rose-
mary leaves extract, and olive and rosemary leaves extracts
was not signiﬁcantly different from those of controls (Table 2).4. Discussion
The present decline in levels of serum glucose, total protein
and albumin with the increases of serum triglycerides, choles-
terol, LDL-C and VLDL-C indicate disturbances in protein,
carbohydrate and lipid metabolism induced by TAA intoxica-
tion. Kruszynska and McIntyre (1991) reported that the blood
sugar level after overnight fasting in cirrhotic patients is
believed to decrease only in severe hepatic failure. Al-Attar
(2012) showed that the level of blood glucose was statistically
decreased in the mice group treated with TAA compared with
control group. Furthermore, several studies showed that car-
bon tetrachloride (CCl4) administration depleted liver glyco-
gen in cirrhotic rats (Favari and Perez-Alvarez, 1997; Muriel
and Escobar, 2003; Muriel et al., 2003; Moreno et al., 2011).
Blood glucose concentration is known to depend on the ability
of the liver to absorb or produce glucose. The liver performs its
glucostatic function owing to its ability to synthesize or
degrade glycogen according to the needs of the organism, as
well as via gluconeogenesis (Ahmed et al., 2006).
The present study showed that the supplementation of olive
leaves extract, rosemary leaves extract, and olive and rosemary
leaves extracts signiﬁcantly decreased the levels of serum glu-
cose in normal rats. Jemai et al. (2009) reported that the oleu-
ropein and tannins in olive leaves act as a-glucosidase
inhibitors, reducing the absorption of carbohydrates in the
gut. Moreover, the extract of olive leaves was shown to have
an inhibitory effect on the postprandial blood increase in glu-
cose in diabetic rats (Komaki et al., 2003). In humans treated
with olive leaves extract, blood glucose was signiﬁcantly
declined after cooked rice loading compared with untreated
controls (Komaki et al., 2003). There have been two possible
mechanisms suggested to explain the hypoglycemic effect of
the olive leaves extract: (1) oleuropein improved glucose-
induced insulin release, and (2) increased peripheral uptake
of glucose (El and Karakaya, 2009). The oleuropein in olive
leaves has been shown to accelerate the cellular uptake of glu-
cose, leading to reduced blood glucose (Gonzalez et al., 1992).
Since oleuropein is a glycoside, it could potentially access a
glucose transporter such as a sodium-dependent glucose trans-
porter found in the epithelial cells of the small intestine,
thereby permitting its entry into the cells (Wolffram et al.,
2002). Experimental investigations point to an interaction
between dietary ﬂavonol monoglucosides with the intestinal
sodium-dependent glucose transporter and inhibited Na-inde-
pendent glucose uptake (Arts et al., 2002; Cermak et al., 2004).
Another way in which olive leaves extract might exert its hypo-
glycemic effect is through the inhibition of pancreatic amylase
activity (Komaki et al., 2003). A possible mechanism of the
hypoglycemic action of rosemary leaves extract was suggestedto be through increasing the insulin level (Vanithadevi and
Anuradha, 2008). Moreover, recent study reported that rose-
mary leaves lead to regeneration of the b-cells of the pancreas
and potentiating of insulin secretion from surviving b-cells,
which indicates that rosemary leaves decrease blood glucose
level by stimulating insulin secretion from the remnant b-cells
or regenerated b-cells (Alnahdi, 2012). Furthermore, the
reduction of fasting blood glucose may be due to that rose-
mary leaves might inhibit the intestinal absorption of glucose
by inhibition of intestinal amylase enzyme or a-glucosidase
enzyme (McCue and Shetty, 2004; Koga et al., 2006).
Several investigators reported that TAA intoxicationmodels
registered signiﬁcantly lower blood total protein levels com-
pared to those of the healthy models (Trennery and Waring,
1983; Galisteo et al., 2006; Jain and Singhai, 2011; Al-Attar,
2011). This alteration could be related to the induction of ubiq-
uitin-associated protein degradation by TAA toxic stress
(Andersen et al.,1981). Tripathi et al. (2003) showed that the
level of serum cholesterol was decreased in adult albino rats
intoxicated with TAA, CCl4 or paracetamol, while Khalaf
et al. (2009) reported that the levels of serum cholesterol and tri-
glycerides were increased in rats intoxicated with CCl4. Ismail
et al. (2009) showed that the levels of serum cholesterol, triglyc-
erides, LDL-C and VLDL-C were increased, while the level of
serum HDL-C was declined in rats exposed to CCl4. Addition-
ally, Al-Attar (2011, 2012) reported that the chronic administra-
tion of TAA increased the levels of blood triglycerides,
cholesterol, CK, LDH and LDL-C, while the levels of glucose,
total protein, albumin were statistically decreased in male rats
and mice.
One of the most valid and reliable methods for assessing
muscular damage is to check for increases in blood serum levels
of CK. CK catalyzes the reversible phosphorylation of creatine
by adenosine triphosphate (ATP) to form creatine phosphate,
the major storage form of high energy phosphate required by
muscle (Cardinet, 1989; Moss and Henderson, 1994). The pres-
ent elevation of serum CK level in TAA-treated rats may be due
to the damage of cardiac muscle tissues. Lactate dehydrogenase
is a hydrogen transfer enzyme that catalyzes the oxidation of L-
lactate to pyruvate with nicotinamide-adenine dinucleotide
(NAD)+ as hydrogen acceptor, the ﬁnal step in the metabolic
chain of anaerobic glycolysis. The reaction is reversible and
the reaction equilibrium strongly favors the reverse reaction,
namely the reduction of pyruvate to lactate. Activity of LDH
is present in almost all cells of the body and is found only in
the cytoplasm of the cell (Moss and Henderson, 1986; Lott
and Nemensanszky; 1987). Generally, high concentrations of
LDH are found in the liver, heart, erythrocytes, skeletal mus-
cles and kidneys. Consequently, diseases affecting those organs,
such as renal infarction, myocardial infarction and hemolysis,
have been reported to be associated with signiﬁcant elevations
in total serum LDH activity. Such elevations have been widely
applied as diagnostic indices for kidney, liver, heart and red
blood cell dysfunction (Wills, 1971; Timmis and Nathan,
1993; Castaldo et al., 1994). Additionally, high serum LDH
activity has also been reported in a variety of cancers
(Kanowski and Clague, 1994). Al-Attar (2011) demonstrated
that the chronic administration of TAA (300 mg/kg body
weight/twice weekly for 10 weeks) induced cardiotoxicity man-
ifested by a signiﬁcant increase in serum of CK and LDH activ-
ities in rats. This is due to leakage from the heart as a result of
TAA induced necrosis (Al-Attar, 2011).
478 A.M. Al-Attar, N.A. ShawushThe present obtained results showed that these extracts
improved the physiological disturbances induced by TAA
intoxication. Moreover, most improvements were observed in
rats supplemented with rosemary leaves extract followed by
olive and rosemary leaves extracts and olive leaves extract.
TAA causes an elevation of oxidative stress, enhancing free
radical mediated damage to proteins, lipids and DNA
(Brucket al., 2004; Tunez et al., 2005; Uskokovic-Markovic
et al., 2007). Several studies have demonstrated the beneﬁcial
effect of antioxidants against TAA toxicity (Uskokovic-
Markovic et al., 2007; Baskaran et al., 2010; Mustafa et al.,
2013; Ali et al., 2014). Olive leaves are a source of several anti-
oxidants (Briante et al., 2002; Bouaziz and Sayadi, 2005;
Meirinhos et al., 2005; Ranalli et al., 2006). Popular medicine
and phytotherapy use olive leaves to treat and prevent several
diseases. Many of these properties have been described as
resulting from the antioxidant character of oleuropein (Visioli
et al., 1998). Most pharmacological effects of rosemary are
the consequence of high antioxidant activity of its main chem-
ical constituents, which include carnosol, carnosic acid, ursolic
acid, rosmarinic acid, and caffeic acid. The potent antioxidant
properties of rosemary have been mainly attributed to its major
diterpenes, carnosol and carnosic acid, as well as to the essential
oil components (Ngo et al., 2011). In the light of this study,
these extracts may play a role in the prevention of physiological
disturbances caused by TAA. These results suggested that the
effect of these extracts might be due to their antioxidant activ-
ities restraining the oxidative stress which is widely associated
with TAA toxicity. Finally, the present study may help to
understand the extent of interaction between the studied
extracts’ administration in toxicants causing physiological
alterations, its prevention in animal model and allowed for pre-
ventive applying in human status.
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